Studies Show Nevisense Helps Find More Melanomas
Studies published in the Journal of the American Academy of Dermatology (JAAD) which included 267 dermatologists and in SKIN, The Journal of Cutaneous Medicine (SKIN) which included 591 clinicians, compared the results of more than 25,000 evaluations of atypical moles using visual evaluations compared to those using visual evaluations and Nevisense combined.
The key study takeaways were more melanomas were spotted, more benign moles were identified, and the number of biopsies needed dropped when Nevisense was used in conjunction with visual exams.
Getting Started: Early Detection is the Best Protection
Advanced Dermatology continues to research, identify and evaluate technology that can improve the standard of care for skin cancer. Ask whether Nevisense makes sense for your care.